Evotec ESG Presentation Deck

evotec ● PAGE 14 ● Since 2014 Member of Evotec's Supervisory Board (2021 Chairperson) Iris Löw-Friedrich CMO & Executive Vice President Development and Medical Practices UCB S.A. Global view and deep experience for best governance Diverse and international Supervisory Board Since 2008, CMO of UCB S.A., Brussels (Belgium) 2001-2009, Member of the Executive Board of Schwarz Pharma AG, responsible for global R&D Since 2019, Member of the Supervisory Board and Chairman of the Audit Committee of Evotec Roland Sackers CFO & Managing Director QIAGEN N.V. . Since 2004, CFO of QIAGEN N.V. 1999-2004, Auditor at Arthur Andersen ● ● ● Constanze Ulmer-Eilfort Partner at Peters, Schönberger & Partner, Munich ● Since 2021 Member of Evotec's Supervisory Board Kasim Kutay CEO Novo Holdings SE Since 2022, Partner of the law firm Peters, Schoenberger & Partner (Munich) 2000-2021, Equity Partner at Baker McKenzie (since 2017, Member of the Global Executive Committee of BMcK) S4DX GmbH, Chair of the Advisory Committee Since 2020 Member of Evotec's Supervisory Board Since 2016, CEO of Novo Holdings A/S 2009-2016, Managing Director, Co-Head of Europe and member of the Global Management Committee at Moelis & Co. ● Since 2019 Member of Evotec's Supervisory Board 2015-2019, CEO of Carrick Therapeutics Ltd, 1985 ● ● 2011-2014, VP Global External R&D at Eli Lilly & Company, Inc 1995-2010, Various positions in the area of drug discovery and development at AstraZeneca Elaine Sullivan CEO Curadh Pharmaceuticals Former Lilly Since 2019 Member of Evotec's Supervisory Board . 2018, Retired from the Management Board of Evotec ● 2007-2018, COO of Evotec 1991 Founding chemist of Oxford Asymmetry International plc (OAI), which was merged with Evotec BioSystems in 2000 ● Mario Polywka Abingdon, Former COO Evotec SE

View entire presentation